ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07656
0,07%
Bitcoin
64.157,80
0,25%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Provectus Biopharmaceuticals Inc (QB) (PVCT)

  7. Provectus Biopharmaceuticals Inc (QB) (PVCT) News

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PVCT
DatumZeitQuelleÜberschriftSymbolFirma
29/02/202415h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/02/202421h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/02/202420h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
22/02/202415h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/02/202417h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
16/02/202423h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/02/202414h05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/02/202421h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/02/202423h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
29/01/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/01/202420h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
29/12/202322h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
22/12/202317h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/12/202322h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
04/12/202318h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/12/202300h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/11/202323h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/11/202317h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/11/202314h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
27/10/202323h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
19/10/202323h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
05/10/202318h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
15/08/202301h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/08/202319h40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
04/08/202318h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/07/202321h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
27/07/202301h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
25/07/202301h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
05/07/202316h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/06/202315h46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:PVCT

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
CCOM
SILVER
SILVER
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
TG
D7G
Nel ASA
DBI
MDAX
MDAX
TG
MBG
MercedesBenz
NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
NYSE
XOM
Exxon Mobil
NASDAQ
AAPL
Apple
NASDAQ
TSLA
Tesla
DBI
TDXP
Tec DAX
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten